CA
BLFS

Clearstead Advisors’s BioLife Solutions BLFS Stock Holding History

Clearstead Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$396 Buy
+14
New +$327 ﹤0.01% 2997
2025
Q3 		– Sell
-475
Closed -$10.2K – 3111
2025
Q2 		$10.2K Hold
475
– – ﹤0.01% 1885
2025
Q1 		$10.8K Hold
475
– – ﹤0.01% 1591
2024
Q4 		$12.3K Hold
475
– – ﹤0.01% 1522
2024
Q3 		$11.9K Buy
+475
New +$11.2K ﹤0.01% 1552

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Clearstead Advisors's BLFS Position: Q2 2026 in Review

Clearstead Advisors opened a new position in BioLife Solutions (BLFS) in Q2 2026: 14 shares worth $396. The stake represents ﹤0.01% of the portfolio and ranks #2997 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in BLFS as recently as Q2 2025.

Clearstead Advisors first reported a position in BLFS in Q3 2024 and has held it in 5 quarters since. The position peaked at $12.3K in Q4 2024. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Clearstead Advisors held 14 shares of BioLife Solutions worth $396 as of Q2 2026.
  • BioLife Solutions was a new Clearstead Advisors position in Q2 2026.
  • BioLife Solutions made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2997 holding.
  • Clearstead Advisors first reported a position in BioLife Solutions in Q3 2024 and has held it in 5 quarters since.
  • Clearstead Advisors's BioLife Solutions position peaked at $12.3K in Q4 2024.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.